Barbados Banana Ice-Cream

Barbados Banana Ice-Cream

If you are looking for the best and most diverse selection of marijuana recipes online, you have arrived at the right place. Whether you are a seasoned or a first-time cannabis chef, there is a marijuana recipe for you.

Ingredients (for serving six):

  • 25 gram butter
  • 18FL Oz Single Cream
  • 1/4 Ounce Crumbled hash
  • 75 gram sugar
  • Pinch salt
  • 3 overripe Bananas
  • 3 Tablespoons Rum
  • 5 Tablespoons Honey


In a saucepan, take the cream and heat until nearly boiling. In another saucepan, melt the butter with salt and sugar. Heat the hash with a flame and crumble it into the melted butter and keep stirring all the time. Once done, whisk the cream and butter. You now need to peel bananas and mash them up. Thereafter, add cream, honey, and rum and you may add chocolate chips or smashed up cookies. Beat it to mix and pour it into a covered chilled plastic container. Now, let is freeze for a few hours. Pout into a mixing bowl and whisk until it turns smooth once it is partially set. Now, return the mixture to the container, cover, and freeze until firm.

Pain From Chemotherapy Drugs Could Be Eased By Marijuana Component

marijuana-pain-chemotherapyAccording to researchers at Temple University’s School of Pharmacy, the onset of pain associated with drugs used in chemotherapy could be prevented by a chemical component of the marijuana plant.

The researchers published their findings, “Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice,” in the journal Anesthesia and Analgesia.

The involved researchers developed animal models and tested the potency of the compound cannabidiol that is the second most abundant chemical found in the marijuana plant for relieving chemo-induced neuropathic pain, said Sara Jane Ward, research assistant professor of pharmaceutical sciences in Temple’s School of Pharmacy and the study’s lead author.

“We found that cannabidiol completely prevented the onset of the neuropathic, or nerve pain caused by the chemo drug Paclitaxel, which is used to treat breast cancer,” said Ward, who is also a research associate professor in Temple’s Center for Substance Abuse Research.

One of cannabidiol‘s major benefits is that it does not produce psycho-active effects such as euphoria, increased appetite or cognitive deficits, as per Ward. “Cannabidiol has the therapeutic qualities of marijuana but not the side effects,” she said.

Marijuana binds to the cannabinoid receptors in the body and researchers have long been interested in whether there is therapeutic potential for targeting this receptor system,” she said.

Ward further said cannabidiol has also demonstrated the ability to decrease tumor activity in animal models that could make it an effective therapeutic for breast cancer, especially if you “combined it with a chemo agent like Paclitaxel, which we already know works well.”

The study was supported by grants from the National Institutes of Health and the Peter F. McManus Charitable Trust.


Temple University. (2011, October 10)

Marijuana Does Not Increase Risk Of Head and Neck Cancer

Otolaryngology Marijuana According to a study published in an issue Otolaryngology – Head and Neck Surgery, smoking marijuana (cannabis) does not increase the user’s risk of head and neck cancer. The small sample study was authored by researchers from New Zealand and Great Britain and found that the relative risk of smoking cannabis and contracting head and neck cancer in marijuana users was the same (1.0) as in those who had never smoked cannabis among 75 cases of head and neck cancer.

The results differ from the relative risk of contracting cancer from smoking cigarettes (2.1) and the heavy consumption of alcohol (5.7), compared with those who abstained from those activities. The authors cannot exclude other possible effects, and recommended a larger study because of limits of the study.

The study authors are Sarah Aldington, BMBS; Matire Harwood, MBChB; Brian Cox, PhD; Mark Weatherall, FRACP; Lutz Beckertz, MD; Anna Hansell, PhD; Alison Prithchard; Geoffrey Robinson, FRACP; and Richard Beasley, DSc. The study was conducted on behalf of the Cannabis and Respiratory Disease Research Group.